07-10-2021, 07:48 AM
The acting head of the Food and Drug Administration is calling for a government investigation into highly unusual contacts between her agency’s drug reviewers and the maker of a controversial new Alzheimer’s drug
[url="https://abcnews.go.com/Business/wireStory/fda-head-calls-probe-alzheimers-drug-review-78758507"]Continue reading...[/url]
[url="https://abcnews.go.com/Business/wireStory/fda-head-calls-probe-alzheimers-drug-review-78758507"]Continue reading...[/url]